These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22171766)

  • 21. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the WHI relevant to HRT started in the perimenopause?
    Harman SM; Brinton EA; Clarkson T; Heward CB; Hecht HS; Karas RH; Judelson DR; Naftolin F
    Endocrine; 2004 Aug; 24(3):195-202. PubMed ID: 15542885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further evidence for promoting transdermal estrogens in the management of postmenopausal symptoms.
    Canonico M; Scarabin PY
    Menopause; 2011 Oct; 18(10):1038-9. PubMed ID: 21946050
    [No Abstract]   [Full Text] [Related]  

  • 24. From the challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health.
    Gambacciani M; Genazzani AR
    Gynecol Endocrinol; 2006 Mar; 22(3):115-6. PubMed ID: 16835071
    [No Abstract]   [Full Text] [Related]  

  • 25. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
    von Schoultz B
    Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
    [No Abstract]   [Full Text] [Related]  

  • 26. Estradiol associated with lower thrombotic risk than conjugated equine estrogens when used as oral HRT.
    Brown S
    Menopause Int; 2013 Dec; 19(4):145. PubMed ID: 24479171
    [No Abstract]   [Full Text] [Related]  

  • 27. Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
    Grant EC
    J Natl Cancer Inst; 2011 Jul; 103(13):1069; reply 1069-70. PubMed ID: 21700925
    [No Abstract]   [Full Text] [Related]  

  • 28. HRT, HERS, NIH, WHI: alphabet soup?
    Legato MJ
    J Gend Specif Med; 2002; 5(6):10-3. PubMed ID: 12503220
    [No Abstract]   [Full Text] [Related]  

  • 29. Adverse neoplastic and cardiovascular outcomes of HRT: the validity of the evidence.
    Shapiro S
    Endocrine; 2004 Aug; 24(3):203-10. PubMed ID: 15542886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postmenopausal hormone therapy initiation before and after the Women's Health Initiative in two French cohorts.
    Fournier A; Kernaleguen C; Panjo H; Clavel-Chapelon F; Ringa V
    Menopause; 2011 Feb; 18(2):219-23. PubMed ID: 21052030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical pharmacology and differential cognitive efficacy of estrogen preparations.
    Gleason CE; Carlsson CM; Johnson S; Atwood C; Asthana S
    Ann N Y Acad Sci; 2005 Jun; 1052():93-115. PubMed ID: 16024754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hormone replacement therapy in peri- and postmenopause].
    Henes M; Hübner S
    Internist (Berl); 2020 Jun; 61(6):558-564. PubMed ID: 32333087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letter by Micheletti and Chevallier regarding article, "Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER Study".
    Micheletti MC; Chevallier T
    Circulation; 2007 Sep; 116(13):e362; author reply e363. PubMed ID: 17893283
    [No Abstract]   [Full Text] [Related]  

  • 34. Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.
    Dahmoun M; Odmark IS; Risberg B; Karlsson MG; Pavlenko T; Bäckström T
    Maturitas; 2004 Oct; 49(2):114-23. PubMed ID: 15474755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hormone replacement: side effects and problems].
    Kueng F
    Ther Umsch; 2000 Oct; 57(10):643-5. PubMed ID: 11081376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postmenopausal hormone replacement therapy use and risk of endometrial cancer in Japanese women.
    Mizunuma H; Honjo H; Aso T; Urabe M; Ohta H; Kobayashi S; Sagara Y; Sanada M; Tanaka K; Dobashi K; Hayashi K; Ohama K
    Climacteric; 2001 Dec; 4(4):293-8. PubMed ID: 11770185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endometrial effect of progesterone delivered by vaginal rings in estrogen-treated postmenopausal women.
    Noé G; Sitruk-Ware R; Zegers-Hochschild F; Variano B; Montero JC; Arriagada P; Li A; Stanczyk FZ; Felix JC; Mishell DR; Croxatto HB
    Climacteric; 2010 Oct; 13(5):433-41. PubMed ID: 20642326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens.
    Scarabin PY; Hemker HC; Clément C; Soisson V; Alhenc-Gelas M
    Menopause; 2011 Aug; 18(8):873-9. PubMed ID: 21487317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer issues.
    Marsden J; Sturdee D
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormone therapy. An update on risks and benefits.
    Mayo Clin Womens Healthsource; 2009 Mar; Suppl():1-8. PubMed ID: 19405167
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.